Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
View Top Employees from Sophiris Bio Inc.Website | http://www.sophirisbio.com/ |
Ticker | SPHS |
Revenue | $8 million |
Funding | $117 million |
Employees | 5 (3 on RocketReach) |
Founded | 2002 |
Address | 1258 Prospect St, La Jolla, California 92037, US |
Phone | (858) 777-1760 |
Fax | (858) 412-5693 |
Technologies |
HTML,
Twitter,
CloudFlare CDN
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Drug Discovery, Business Services |
Web Rank | 11 Million |
Keywords | Topsalysin, Sophiris Bio, Sophiris, Sphs, Sophiris Offering |
Competitors | Curemark, LLC, Elasmogen Ltd, Laurent Pharmaceuticals, Lisata Therapeutics, Inc., Oculis |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Sophiris Bio Inc. employee's phone or email?
The Sophiris Bio Inc. annual revenue was $8 million in 2024.
3 people are employed at Sophiris Bio Inc..
Sophiris Bio Inc. is based in La Jolla, California.
The NAICS codes for Sophiris Bio Inc. are [3254, 32, 32541, 325].
The SIC codes for Sophiris Bio Inc. are [283, 28].